Search Results 441-450 of 16979 for pharmacogenetics
Aim 1: To determine the metabolic effects of decreasing circulating EOS in healthy subjects. Mepolizumab is an FDA-approved drug that selectively reduces ...
Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) · Overview.
As scientists at the Mayo Clinic Center for Individualized Medicine discover new ways to use genomic information in the diagnosis, treatment and prevention of ...
About this study. The primary objective of the study is to utilize comprehensive, family-centered genomic screening strategies - chromosomal microarray ...
Mayo Clinic researchers studying the genetics of people who had recently developed dilated cardiomyopathy, one of the most common causes of heart failure, have ...
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “D” to learn about drug side effects, proper use and ...
A patient's genes may affect the risk of developing complications, such as congestive heart failure, heart attack, stroke, and second cancer, years after ...
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.